These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

693 related items for PubMed ID: 18316553

  • 21. [HIF-1alpha, HIF-2alpha and VHL mRNA expression in different cell lines during hypoxia].
    Bobarykina AIu, Minchenko DO, Opentanova IL, Kovtun OO, Komisarenko SV, Esumi H, Minchenko OH.
    Ukr Biokhim Zh (1999); 2006; 78(2):62-72. PubMed ID: 17100286
    [Abstract] [Full Text] [Related]

  • 22. Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B.
    Krishnamachary B, Zagzag D, Nagasawa H, Rainey K, Okuyama H, Baek JH, Semenza GL.
    Cancer Res; 2006 Mar 01; 66(5):2725-31. PubMed ID: 16510593
    [Abstract] [Full Text] [Related]

  • 23. Inactivation of von Hippel-Lindau increases ovarian cancer cell aggressiveness through the HIF1α/miR-210/VMP1 signaling pathway.
    Liu T, Zhao L, Chen W, Li Z, Hou H, Ding L, Li X.
    Int J Mol Med; 2014 May 01; 33(5):1236-42. PubMed ID: 24549370
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis.
    McCormick RI, Blick C, Ragoussis J, Schoedel J, Mole DR, Young AC, Selby PJ, Banks RE, Harris AL.
    Br J Cancer; 2013 Mar 19; 108(5):1133-42. PubMed ID: 23449350
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Hypoxia-inducible factor-2alpha regulates the expression of TRAIL receptor DR5 in renal cancer cells.
    Mahajan S, Dammai V, Hsu T, Kraft AS.
    Carcinogenesis; 2008 Sep 19; 29(9):1734-41. PubMed ID: 18544564
    [Abstract] [Full Text] [Related]

  • 28. Expression of VHL and HIF-1α and Their Clinicopathologic Significance in Benign and Malignant Lesions of the Gallbladder.
    Yang Z, Yang Z, Xiong L, Huang S, Liu J, Yang L, Miao X.
    Appl Immunohistochem Mol Morphol; 2011 Dec 19; 19(6):534-9. PubMed ID: 21415706
    [Abstract] [Full Text] [Related]

  • 29. MicroRNA-363 and GATA-1 are regulated by HIF-1α in K562 cells under hypoxia.
    Xie Y, Li W, Feng J, Wu T, Li J.
    Mol Med Rep; 2016 Sep 19; 14(3):2503-10. PubMed ID: 27485543
    [Abstract] [Full Text] [Related]

  • 30. MicroRNA-101 targets von Hippel-Lindau tumor suppressor (VHL) to induce HIF1α mediated apoptosis and cell cycle arrest in normoxia condition.
    Liu N, Xia WY, Liu SS, Chen HY, Sun L, Liu MY, Li LF, Lu HM, Fu YJ, Wang P, Wu H, Gao JX.
    Sci Rep; 2016 Feb 04; 6():20489. PubMed ID: 26841847
    [Abstract] [Full Text] [Related]

  • 31. Expression of HIF-1α and Markers of Angiogenesis Are Not Significantly Different in Triple Negative Breast Cancer Compared to Other Breast Cancer Molecular Subtypes: Implications for Future Therapy.
    Yehia L, Boulos F, Jabbour M, Mahfoud Z, Fakhruddin N, El-Sabban M.
    PLoS One; 2015 Feb 04; 10(6):e0129356. PubMed ID: 26046764
    [Abstract] [Full Text] [Related]

  • 32. Thymosin β4 expression correlates with lymph node metastasis through hypoxia inducible factor-α induction in breast cancer.
    Yoon SY, Lee HR, Park Y, Kim JH, Kim SY, Yoon SR, Lee WJ, Cho BJ, Min H, Bang JW, Park H, Bang SI, Cho D.
    Oncol Rep; 2011 Jan 04; 25(1):23-31. PubMed ID: 21109953
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. HER2 regulates HIF-2α and drives an increased hypoxic response in breast cancer.
    Jarman EJ, Ward C, Turnbull AK, Martinez-Perez C, Meehan J, Xintaropoulou C, Sims AH, Langdon SP.
    Breast Cancer Res; 2019 Jan 22; 21(1):10. PubMed ID: 30670058
    [Abstract] [Full Text] [Related]

  • 35. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
    Zatyka M, da Silva NF, Clifford SC, Morris MR, Wiesener MS, Eckardt KU, Houlston RS, Richards FM, Latif F, Maher ER.
    Cancer Res; 2002 Jul 01; 62(13):3803-11. PubMed ID: 12097293
    [Abstract] [Full Text] [Related]

  • 36. Differential distribution of miR-20a and miR-20b may underly metastatic heterogeneity of breast cancers.
    Li JY, Zhang Y, Zhang WH, Jia S, Kang Y, Zhu XY.
    Asian Pac J Cancer Prev; 2012 Jul 01; 13(5):1901-6. PubMed ID: 22901144
    [Abstract] [Full Text] [Related]

  • 37. Kelch-like 20 up-regulates the expression of hypoxia-inducible factor-2α through hypoxia- and von Hippel-Lindau tumor suppressor protein-independent regulatory mechanisms.
    Higashimura Y, Terai T, Yamaji R, Mitani T, Ogawa M, Harada N, Inui H, Nakano Y.
    Biochem Biophys Res Commun; 2011 Sep 23; 413(2):201-5. PubMed ID: 21888897
    [Abstract] [Full Text] [Related]

  • 38. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
    Bos R, van der Groep P, Greijer AE, Shvarts A, Meijer S, Pinedo HM, Semenza GL, van Diest PJ, van der Wall E.
    Cancer; 2003 Mar 15; 97(6):1573-81. PubMed ID: 12627523
    [Abstract] [Full Text] [Related]

  • 39. Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions.
    Chae KS, Kang MJ, Lee JH, Ryu BK, Lee MG, Her NG, Ha TK, Han J, Kim YK, Chi SG.
    Oncogene; 2011 Mar 10; 30(10):1213-28. PubMed ID: 21057546
    [Abstract] [Full Text] [Related]

  • 40. Role of ETS transcription factors in the hypoxia-inducible factor-2 target gene selection.
    Aprelikova O, Wood M, Tackett S, Chandramouli GV, Barrett JC.
    Cancer Res; 2006 Jun 01; 66(11):5641-7. PubMed ID: 16740701
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.